• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Treatment of rheumatic diseases with nabumetone. Results of a study using the drug in 18,046 patients].

作者信息

Lemmel E M, Stroehmann I

出版信息

Fortschr Med. 1988 Apr 20;106(12):253-6.

PMID:3260888
Abstract
摘要

相似文献

1
[Treatment of rheumatic diseases with nabumetone. Results of a study using the drug in 18,046 patients].[萘丁美酮治疗风湿性疾病。18046例患者使用该药物的研究结果]
Fortschr Med. 1988 Apr 20;106(12):253-6.
2
[Nabumetone].萘丁美酮
Rev Med Univ Navarra. 1995 Jul-Sep;39(3):164-72.
3
Efficacy and safety of nabumetone in patients with rheumatic diseases. Results of an outpatient study involving 8,865 patients.萘丁美酮在风湿性疾病患者中的疗效与安全性。一项涉及8865例患者的门诊研究结果。
Drugs. 1990;40 Suppl 5:50-2. doi: 10.2165/00003495-199000405-00012.
4
Clinical efficacy and tolerance of nabumetone in articular and non-articular rheumatic disorders: personal experience during 12 weeks of treatment.萘丁美酮在关节和非关节风湿性疾病中的临床疗效及耐受性：12周治疗期的个人经验
Panminerva Med. 1998 Jun;40(2):110-5.
5
[Efficacy and tolerability of nabumetone in the treatment of painful symptomatology of rheumatoid arthritis and osteoarthrosis].萘丁美酮治疗类风湿性关节炎和骨关节炎疼痛症状的疗效及耐受性
Clin Ter. 1991 May 15;137(3):185-9.
6
Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.萘丁美酮。对其在风湿性疾病中的药理学及治疗应用的重新评估。
Drugs. 1993 Jan;45(1):131-56. doi: 10.2165/00003495-199345010-00009.
7
Efficacy and safety of nabumetone in 4,541 elderly patients from a drug monitoring study.
Drugs. 1990;40 Suppl 5:62-4. doi: 10.2165/00003495-199000405-00015.
8
Controlled evaluation of nabumetone in the treatment of active adult rheumatoid arthritis. Nabumetone versus naproxen double-blind parallel study.
Am J Med. 1987 Oct 30;83(4B):55-9. doi: 10.1016/0002-9343(87)90595-x.
9
Nabumetone: a new NSAID for rheumatoid arthritis and osteoarthritis.
Orthop Rev. 1992 Feb;21(2):223-7.
10
Nabumetone (Relifex)--another NSAID.
Drug Ther Bull. 1988 May 31;26(11):41-3. doi: 10.1136/dtb.26.11.41.

引用本文的文献

1
Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.萘丁美酮。对其在风湿性疾病中的药理学及治疗应用的重新评估。
Drugs. 1993 Jan;45(1):131-56. doi: 10.2165/00003495-199345010-00009.
2
Efficacy and safety of nabumetone in 5,421 patients with osteoarthritis of the hip and/or knee joints. A subgroup evaluation of an outpatient study involving 18,047 patients.萘丁美酮在5421例髋和/或膝关节骨关节炎患者中的疗效和安全性。一项涉及18047例患者的门诊研究的亚组评估。
Drugs. 1990;40 Suppl 5:75-7. doi: 10.2165/00003495-199000405-00019.
3
Efficacy and safety of nabumetone in 4,541 elderly patients from a drug monitoring study.
Drugs. 1990;40 Suppl 5:62-4. doi: 10.2165/00003495-199000405-00015.
4
Efficacy and safety of nabumetone in patients with rheumatic diseases. Results of an outpatient study involving 8,865 patients.萘丁美酮在风湿性疾病患者中的疗效与安全性。一项涉及8865例患者的门诊研究结果。
Drugs. 1990;40 Suppl 5:50-2. doi: 10.2165/00003495-199000405-00012.
5
German drug monitoring studies with nabumetone.德国对萘丁美酮进行的药物监测研究。
Drugs. 1990;40 Suppl 5:38-42. doi: 10.2165/00003495-199000405-00009.